Antimicrobial Packaging - Global Strategic Business Report

Global Antimicrobial Packaging Market to Reach $13.5 Billion by 2030

The global market for Antimicrobial Packaging estimated at US$9.3 Billion in the year 2022, is projected to reach a revised size of US$13.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2022-2030. Plastics, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$7.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biopolymers segment is readjusted to a revised 5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 4.5% CAGR

The Antimicrobial Packaging market in the U.S. is estimated at US$2.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 46 Featured) -

• Amcor Ltd.
• BASF SE
• Bayer AG
• Biocote Limited
• Clariant AG
• Dow, Inc.
• DuPont de Nemours, Inc.
• Dunmore Corporation
• Microban International Ltd.
• Mondi PLC
• PARX Plastics N.V.
• PolyOne Corporation

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year